173 related articles for article (PubMed ID: 16595387)
1. Economic costs of Oxford House inpatient treatment and incarceration: a preliminary report.
Olson BD; Viola J; Jason LA; Davis MI; Ferrari JR; Rabin-Belyaev O
J Prev Interv Community; 2006; 31(1-2):63-72. PubMed ID: 16595387
[TBL] [Abstract][Full Text] [Related]
2. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
3. Unit cost of counseling and patients length of stay in a residential drug treatment setting.
Alemi F; Haack M; Holifield L; Claudio Y; Haqqi K
J Ment Health Policy Econ; 2002 Sep; 5(3):103-7. PubMed ID: 12728196
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of inpatient residential treatment programs in the Department of Veterans Affairs.
Wagner TH; Chen S
Med Care Res Rev; 2005 Apr; 62(2):187-204. PubMed ID: 15750176
[TBL] [Abstract][Full Text] [Related]
5. Costs and benefits of combining probation and substance abuse treatment.
Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
[TBL] [Abstract][Full Text] [Related]
6. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
Cartwright WS
J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
[TBL] [Abstract][Full Text] [Related]
7. Costing substance misuse services.
Coyle D; Godfrey C; Hardman G; Raistrick D
Addiction; 1997 Aug; 92(8):1007-15. PubMed ID: 9376770
[TBL] [Abstract][Full Text] [Related]
8. Managed care and the quality of substance abuse treatment.
Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
[TBL] [Abstract][Full Text] [Related]
9. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
10. Mental health parity legislation, cost-sharing and substance-abuse treatment admissions.
Dave D; Mukerjee S
Health Econ; 2011 Feb; 20(2):161-83. PubMed ID: 20029912
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
Yeom HS; Shepard DS
J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
[TBL] [Abstract][Full Text] [Related]
12. Patterns of mental health utilization and costs among children in a privately insured population.
Leslie DL; Rosenheck RA; Horwitz SM
Health Serv Res; 2001 Apr; 36(1 Pt 1):113-27. PubMed ID: 11324739
[TBL] [Abstract][Full Text] [Related]
13. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
Parthasarathy S; Weisner CM
Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of family-based substance abuse treatment.
Morgan TB; Crane DR
J Marital Fam Ther; 2010 Oct; 36(4):486-98. PubMed ID: 21039660
[TBL] [Abstract][Full Text] [Related]
16. Benefits and costs associated with mutual-help community-based recovery homes: The Oxford House model.
Lo Sasso AT; Byro E; Jason LA; Ferrari JR; Olson B
Eval Program Plann; 2012 Feb; 35(1):47-53. PubMed ID: 22054524
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
Yamada T; Chen CC; Yamada T
Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
[TBL] [Abstract][Full Text] [Related]
18. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
Fleming E; Lien H; Ma CT; McGuire TG
J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
[TBL] [Abstract][Full Text] [Related]
19. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
Godfrey C; Stewart D; Gossop M
Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
[TBL] [Abstract][Full Text] [Related]
20. This is my neighborhood: comparing United States and Australian Oxford House Neighborhoods.
Ferrari JR; Jason LA; Blake R; Davis MI; Olson BD
J Prev Interv Community; 2006; 31(1-2):41-9. PubMed ID: 16595385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
